e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
COPD: from biomarker profiling to clinical assessment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endogenous hydrogen sulfide reduces airway hyperresponsiveness and airway inflammation in a rat model of chronic obstructive pulmonary disease
Y. Chen, P. Wang, Y. Qi, W. Yao, C. Tang (Beijing, China)
Source:
Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Session:
COPD: from biomarker profiling to clinical assessment
Session type:
E-Communication Session
Number:
3161
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Chen, P. Wang, Y. Qi, W. Yao, C. Tang (Beijing, China). Endogenous hydrogen sulfide reduces airway hyperresponsiveness and airway inflammation in a rat model of chronic obstructive pulmonary disease. Eur Respir J 2009; 34: Suppl. 53, 3161
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness
Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation
Year: 2006
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
The role of small airways in obstructive airway diseases
Source: Eur Respir Rev 2011; 20: 23-33
Year: 2011
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 640-646
Year: 2005
Cytokine-mediated reactive oxygen species hyperproduction in the airway inflammation of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 178s
Year: 2003
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
PG6 Assessing and monitoring airway inflammation in asthma andÿchronic obstructive pulmonary disease
Source: Milan 2017 - Educational material
Year: 2017
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006
Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004
The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept